nctId,briefTitle,overallStatus,whyStopped,phases,conditions,drug_raw,intervention_type
NCT03606642,SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy,TERMINATED,"The DSMC March 16, 2022 reviewed of Interim Analysis and recommendation due to no glaring outcomes found to date.",PHASE2,Coronary Artery Disease | Atherosclerosis | Stent Placement,Dual Antiplatelet (DAPT) Therapy,DRUG
NCT02953496,Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries,WITHDRAWN,Change in operating plans,PHASE1,Peripheral Artery Disease,vonapanitase,DRUG
NCT00554541,Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease,TERMINATED,Lack of study subjects,,Obesity | Peripheral Arterial Disease,,
NCT03455374,Diamondback in Peripheral Vascular Disease,TERMINATED,PI/Sponsor mutual agreement due to poor enrollment,NA,Peripheral Vascular Diseases | Critical Limb Ischemia,,
NCT04109287,Blood Flow Changes in Femoral-popliteal Bypass Grafts After Neuromuscular Electrical Stimulation (NMES).,WITHDRAWN,COVID-19,NA,Peripheral Arterial Disease | Peripheral Artery Disease | Peripheral Vascular Disease | Femoral Popliteal Occlusion,,
NCT05566678,Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease,WITHDRAWN,"The study was stopped before enrollment, after a feasibility review revealed we would be unable to measure the primary endpoint (flow mediated dilation - FMD) with a high degree of reproducibility and minimum variability in a multi-country setting.",NA,Cardiovascular Diseases | Smoking | Tobacco Use | Peripheral Arterial Disease | Coronary Artery Disease,,
NCT01559974,Vitamin D and Walking Ability in Patients With Peripheral Artery Occlusive Disease,TERMINATED,Insufficient recruitment,PHASE4,Peripheral Arterial Disease,Placebo,DRUG
NCT01559974,Vitamin D and Walking Ability in Patients With Peripheral Artery Occlusive Disease,TERMINATED,Insufficient recruitment,PHASE4,Peripheral Arterial Disease,Cholecalciferol,DRUG
NCT05757752,Mind Body Program for Vascular Disease,WITHDRAWN,No participants enrolled,NA,Peripheral Arterial Disease | Peripheral Vascular Diseases,,
NCT03240068,Angiotensin-(1-7) in Peripheral Arterial Disease,TERMINATED,Study funding ended prior to completion.,EARLY_PHASE1,Peripheral Arterial Disease,Angiotensin 1-7,DRUG
NCT03240068,Angiotensin-(1-7) in Peripheral Arterial Disease,TERMINATED,Study funding ended prior to completion.,EARLY_PHASE1,Peripheral Arterial Disease,Saline,DRUG
NCT04059536,Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO),WITHDRAWN,Sponsor decision,,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Acetylsalicylic Acid,DRUG
NCT04059536,Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO),WITHDRAWN,Sponsor decision,,Chronic Total Occlusion | Atherosclerosis | Coronary Artery Disease | Peripheral Artery Disease,Heparin,DRUG
NCT00311311,Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients,TERMINATED,See termination reason in detailed description.,PHASE3,Atherosclerosis | Kidney Failure,tacrolimus,DRUG
NCT00311311,Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients,TERMINATED,See termination reason in detailed description.,PHASE3,Atherosclerosis | Kidney Failure,mycophenolate mofetil,DRUG
NCT00311311,Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients,TERMINATED,See termination reason in detailed description.,PHASE3,Atherosclerosis | Kidney Failure,prednisone,DRUG
NCT00311311,Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients,TERMINATED,See termination reason in detailed description.,PHASE3,Atherosclerosis | Kidney Failure,sirolimus,DRUG
NCT01731990,"Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease",TERMINATED,The study got terminated based on result from primary endpoint analysis,PHASE2,Peripheral Artery Disease,Canakinumab (ACZ885),DRUG
NCT01731990,"Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease",TERMINATED,The study got terminated based on result from primary endpoint analysis,PHASE2,Peripheral Artery Disease,Placebo,DRUG
NCT02144610,Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia,TERMINATED,,PHASE3,Critical Limb Ischemia,HGF Plasmid (AMG0001),BIOLOGICAL
NCT02144610,Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia,TERMINATED,,PHASE3,Critical Limb Ischemia,Matching Placebo,BIOLOGICAL
NCT00491751,Clinical Utility of Endothelial Dysfunction in PAD,TERMINATED,Insufficient enrollment,PHASE1,Peripheral Arterial Disease,atorvastatin,DRUG
NCT00491751,Clinical Utility of Endothelial Dysfunction in PAD,TERMINATED,Insufficient enrollment,PHASE1,Peripheral Arterial Disease,ascorbic acid,DRUG
NCT00491751,Clinical Utility of Endothelial Dysfunction in PAD,TERMINATED,Insufficient enrollment,PHASE1,Peripheral Arterial Disease,Placebo,DRUG
NCT02433587,Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization,WITHDRAWN,Never recruited any patients.,PHASE3,Peripheral Arterial Disease | Endovascular Procedures,Aspirin,DRUG
NCT02433587,Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization,WITHDRAWN,Never recruited any patients.,PHASE3,Peripheral Arterial Disease | Endovascular Procedures,Clopidogrel,DRUG
NCT02399852,Effects of Lomitapide on Carotid and Aortic Atherosclerosis,WITHDRAWN,,,Homozygous Familial Hypercholesterolemia,Lomitapide,DRUG
NCT02374957,Cilostazol After Lower Extremity Arterial Revascularization Trial,TERMINATED,Original PI left institution,PHASE4,Peripheral Arterial Disease | Claudication (Finding),Cilostazol,DRUG
NCT03247972,Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease,TERMINATED,Research group transferred to another hospital,,Peripheral Arterial Disease,Evolocumab,DRUG
NCT05629767,Tracking of Lipid Lowering Therapy in Jordan,TERMINATED,Inadequate enrolling numbers of patients,,Dyslipidemias | Atherosclerotic Cardiovascular Disease,,
NCT01030328,AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis,WITHDRAWN,Lack of patient population,PHASE3,Coronary Atherosclerosis,Placebo,DRUG
NCT01030328,AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis,WITHDRAWN,Lack of patient population,PHASE3,Coronary Atherosclerosis,TriLipix,DRUG
NCT00111826,SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes,TERMINATED,,PHASE3,Peripheral Arterial Disease | Arterial Occlusive Diseases | Intermittent Claudication,,
NCT02230527,Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia,TERMINATED,Lack of enrollment,PHASE2|PHASE3,Peripheral Arterial Disease,Ticagrelor,DRUG
NCT02230527,Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia,TERMINATED,Lack of enrollment,PHASE2|PHASE3,Peripheral Arterial Disease,Clopidogrel,DRUG
NCT00458497,Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain,TERMINATED,Low enrollment,NA,Diabetic Neuropathy | Arthritis | Peripheral Arterial Disease | Plantar Fasciitis,,
NCT02136537,Electrical Stimulation in Peripheral Arterial Disease,TERMINATED,Member of staff moved on to training post. Trial halted and terminated,NA,Peripheral Arterial Disease,,
NCT01279395,Anti-inflammatory Agents and Cholesterol Metabolism,TERMINATED,Could not recruit adequate number of subjectsa,,Osteoarthritis,,
NCT02286401,Functional Assessment of Coronary Artery Disease by CTA Flow Encoding,TERMINATED,Recruitment lagged behind goal;exhaustion of funding.,,Coronary Artery Disease,,
NCT02531139,The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery,WITHDRAWN,Study was not feasible.,NA,Anesthesia | Peripheral Arterial Diseases,,
NCT00554073,Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T,SUSPENDED,It was not possible to perform 2 MRI studies in each patient due to practical problems. The study was not suspended due to safety issues.,,Atherosclerosis | Intermittent Claudication | MRI,,
NCT03730571,The AbsorbaSeal Vascular Closure Device Trial,TERMINATED,Insufficient closure,NA,Peripheral Arterial Disease,,
NCT02043951,Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity,TERMINATED,Originally 500 patients were planned but only 59 have been enrolled,,Peripheral Artery Disease,,
NCT00932048,Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes,WITHDRAWN,,NA,Type 2 Diabetes | Atherosclerosis,Atorvastatin,DRUG
NCT01268319,CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow,TERMINATED,,NA,Coronary Atherosclerosis | Myocardial Infarction | Coronary Plaque Embolization,,
NCT02767895,Prehabilitation for PAD Revascularization Patients,TERMINATED,Difficulty with enrollment and change in available study resources,NA,Peripheral Vascular Disease | Peripheral Artery Disease,,
NCT04642066,"Cold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters",SUSPENDED,funding not obtained,NA,Cardiovascular Risk Factor | Metabolic Complication | Endocrine; Complications | Immune System Diseases,,
NCT02539303,Delivery of Yamani-15/5 Chemical Solution for PAD,WITHDRAWN,Unable to enroll subjects,PHASE1,Peripheral Arterial Disease,Yamani-15/5 chemical solution,DRUG
NCT01522742,Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study,TERMINATED,,,Psoriasis,,
NCT02046226,Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia,TERMINATED,inability to meet enrollment goals in this subject population,NA,Critical Limb Ischemia,,
NCT06387355,Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization,WITHDRAWN,Intent to fund was rescinded,NA,Peripheral Artery Disease | Coronary Artery Disease,,
NCT04010045,REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study,TERMINATED,Sponsor stopped the study for business reasons as site recruitment and subject enrollment have not met expectations.,,Peripheral Artery Disease,,
NCT03891641,Momentum-enabled Treadling Methodology to Improve Gait and Enhance Mobility,TERMINATED,COVID-19 continues to prevent recruitment of people over the age of 65 years.,NA,Peripheral Arterial Disease,,
NCT02492854,Standard Versus PICO Dressings in Lower-Extremity Bypass Patients,TERMINATED,PI decided not to proceed with the major amendment and switching to the new generation of the device due to lack of funding.,NA,Of Bypass Graft of the Extremities | Peripheral Arterial Disease | Vascular Diseases | Cardiovascular Diseases,,
NCT01290770,Search a Correlation Between Lp(a) Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina,TERMINATED,,,Atherosclerosis,,
NCT01000181,Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT,SUSPENDED,Difficulty producing tracer,,Carotid Atherosclerosis,,
NCT02004951,BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions,TERMINATED,Batch recall for Misago Terumo self-expanding peripheral stent systems.(withdrawal from the market),NA,Peripheral Arterial Disease | Femoropopliteal Lesions,,
NCT02477540,A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia,WITHDRAWN,Study was stopped by sponsers internal reason.,PHASE1,Critical Limb Ischemia,Cellgram-CLI,DRUG
NCT00578578,Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels,TERMINATED,CRP is no longer SOC - enrollment halted and will analyze available data.,PHASE4,Coronary Artery Disease | Inflammatory Response | Atherosclerosis,,
NCT01082562,Safety Study of BMS-844421 for Treatment of Hypercholesterolemia,TERMINATED,,PHASE1,Atherosclerosis | Hypercholesterolemia,BMS-844421,DRUG
NCT01082562,Safety Study of BMS-844421 for Treatment of Hypercholesterolemia,TERMINATED,,PHASE1,Atherosclerosis | Hypercholesterolemia,0.9% sodium chloride injection solution,DRUG
NCT05834673,VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN),TERMINATED,Loss of strategic interest by the funding party. The participants' recruitment rate failed to meet the target within the pre-specified recruitment windows.,NA,Atherosclerotic Cardiovascular Disease (ASCVD) | Coronary Heart Disease (CHD) | Cerebrovascular Disease | Peripheral Arterial Disease (PAD),,
NCT01654042,Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II,WITHDRAWN,No funding obtained,PHASE3,Atrial Fibrillation | Valvular Heart Disease | Deep Vein Thrombosis | Pulmonary Embolism | Peripheral Arterial Disease,,
NCT00651391,Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336),TERMINATED,Slow enrollment,PHASE3,Hypercholesterolemia | Atherosclerosis,Ezetimibe + Simvastatin,DRUG
NCT00651391,Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336),TERMINATED,Slow enrollment,PHASE3,Hypercholesterolemia | Atherosclerosis,Simvastatin,DRUG
NCT00651391,Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336),TERMINATED,Slow enrollment,PHASE3,Hypercholesterolemia | Atherosclerosis,Placebo,DRUG
NCT03507374,PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis,TERMINATED,Funding withdrawn,EARLY_PHASE1,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Alirocumab,DRUG
NCT03507374,PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis,TERMINATED,Funding withdrawn,EARLY_PHASE1,Stroke | Intracranial Atherosclerosis | Intraplaque Hemorrhage,Placebo,DRUG
NCT06852560,A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors,WITHDRAWN,PI has left institution,NA,Breast Cancer,,
NCT00403780,Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia,TERMINATED,low inclusion rate,PHASE4,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,pregabalin,DRUG
NCT00403780,Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia,TERMINATED,low inclusion rate,PHASE4,Critical Limb Ischemia | Arterial Occlusive Disease | Pain | Ischemia,placebo,DRUG
NCT00584467,Genetic and Inflammatory Markers in Cardiovascular Disease (GEM) Registry,TERMINATED,,,Atherosclerosis,,
NCT04815473,AndraValvulotome Post-Market Study,SUSPENDED,The number of evaluated valves were achieved.,NA,Peripheral Arterial Disease,,
NCT02009930,Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service,TERMINATED,Failure to recruit enough subjects,,"Atherosclerosis | Plaque, Atherosclerotic",,
NCT03464851,Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis,TERMINATED,Low enrollment due to inclusion/exclusion criteria,,Carotid Artery Stenosis,,
NCT03559309,"Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia",TERMINATED,COVID-19 Pandemic Measures,PHASE4,Atherosclerosis | Hypercholesterolemia | Post Prandial Lipemia | Cardiovascular Diseases,,
NCT02099500,Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia,WITHDRAWN,no participants enrolled,PHASE1,Critical Limb Ischemia,,
NCT02037113,Outcomes of Femoro-popliteal Disease After Stent Deployment Under Intravascular Ultrasound Guidance,TERMINATED,PI left institution--only 8 subjects were enrolled.,,Peripheral Arterial Disease,,
NCT01808989,Clinical Interest of the TcPO2 Technique,TERMINATED,end of inclusing period,,Claudication,,
NCT04003480,"FRAME, External Support for Lower Limb Autologous Grafts",SUSPENDED,no patients have been enrolled. Study suspended due to change of sponsor priorities during COVID,NA,Peripheral Arterial Disease | Peripheral Artery Disease,,
NCT02678403,Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral Artery Disease TENS-PAD Study / TENS-AOMI,TERMINATED,principal investigator left Toulouse hospital,NA,Peripheral Artery Disease,,
NCT00651378,Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708),TERMINATED,Slow enrollment \[HIGH SCREEN FAILURE RATE\],PHASE4,Hypercholesterolemia | Atherosclerosis | Coronary Artery Disease,Rosuvastatin,DRUG
NCT00651378,Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708),TERMINATED,Slow enrollment \[HIGH SCREEN FAILURE RATE\],PHASE4,Hypercholesterolemia | Atherosclerosis | Coronary Artery Disease,Ezetimibe + Atorvastatin,DRUG
NCT00651378,Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708),TERMINATED,Slow enrollment \[HIGH SCREEN FAILURE RATE\],PHASE4,Hypercholesterolemia | Atherosclerosis | Coronary Artery Disease,Double Atorvastatin,DRUG
NCT02622308,The Effects of INP on Peripheral Circulation in Dialysis Patients and Patients With PAD and Leg Ulcers,TERMINATED,Terminated due to lack of recruitment,NA,Renal Disease | Peripheral Arterial Disease | Arterial Leg Ulcers,,
NCT04176978,PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis,WITHDRAWN,Lack of funding,NA,Psoriatic Arthritis | Atherosclerosis,Rosuvastatin,DRUG
NCT00388843,Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI),WITHDRAWN,PI has left institution,,Carotid Atherosclerosis,,
NCT04046952,Comparing TR Band to Statseal in Conjunction With TR Band II,TERMINATED,Interim analysis at 50% of planned enrollment met prespecified critieria.,NA,Arterial Occlusion | Cardiovascular Diseases | Atherosclerosis | Hematoma | Anticoagulant-induced Bleeding | Coronary Artery Disease,,
NCT04792008,YQ23 Study in Patients With Critical Limb Ischaemia,TERMINATED,Due to business decision,PHASE1|PHASE2,Critical Limb Ischemia,YQ23,BIOLOGICAL
NCT04792008,YQ23 Study in Patients With Critical Limb Ischaemia,TERMINATED,Due to business decision,PHASE1|PHASE2,Critical Limb Ischemia,Matching placebo,BIOLOGICAL
NCT06886620,Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication,TERMINATED,,PHASE3,Intermittent Claudication,Cilostazol 200 mg,DRUG
NCT06886620,Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication,TERMINATED,,PHASE3,Intermittent Claudication,Cilostazol 100 mg,DRUG
NCT04700371,Vessel Deformations and Restenosis After Stenting of the Popliteal Artery,WITHDRAWN,Lack of financial support.,NA,Peripheral Arterial Disease | Popliteal Artery Stenosis,,
NCT02626169,The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation,WITHDRAWN,Pharmaceutical company sponsor withdrew support prior to enrollment of subjects.,PHASE4,Atherosclerosis,Clopidogrel,DRUG
NCT02626169,The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation,WITHDRAWN,Pharmaceutical company sponsor withdrew support prior to enrollment of subjects.,PHASE4,Atherosclerosis,Ticagrelor,DRUG
NCT03914079,"Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease",SUSPENDED,Sponsor due to COVID-19,,Coronary Artery Disease | Cardiovascular Disease,,
NCT00797082,Magnetic Resonance Diabetic Cardiac Stress Imaging,TERMINATED,default of inclusion,PHASE4,Coronary Insufficiency,,
NCT00869375,Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia,TERMINATED,very low enrollment due to low access to study population,NA,Critical Limb Ischemia,,
NCT01078272,The Saint Francis Remote Ischemic Preconditioning Trial (SaFR),TERMINATED,Recruitment inadequate,NA,Coronary Artery Disease,,
NCT01558531,Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis,SUSPENDED,slow enrollment,,Peripheral Arterial Disease,,
NCT02101346,A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake,TERMINATED,Change in scientific information obtained resulting in early cessation of protocol.,NA,Atherosclerosis,,
NCT03382249,Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques,WITHDRAWN,redesign,PHASE1|PHASE2,Carotid Atherosclerosis,,
NCT05234164,HORIZON Prospective Clinical Investigation,TERMINATED,Business decision,NA,Peripheral Arterial Disease,,
NCT00913900,Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease,TERMINATED,Failure to mobilize adequate CD34+ stem cells for minimum study treatment dose.,PHASE1,Critical Limb Ischemia | Arterial Occlusive Disease | Vascular Diseases,autologous CD133+ cells,BIOLOGICAL
NCT01419574,Ultrasound and Other Images of Artery Blockages,TERMINATED,,,Atherosclerosis,,
NCT02053623,Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor,TERMINATED,Technical issues \& lack of funds,,Hypertension | Atrial Fibrillation | Obesity | Heart Failure | Atherosclerosis,,
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Statin,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Aspirin tablet,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Nexlizet,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,LEQVIO,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Vascepa,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Jardiance,DRUG
NCT06280976,Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP),WITHDRAWN,"study withdrawn, no participants enrolled, changes in the study design planned",PHASE4,Coronary Artery Disease | Atherosclerosis | Heart Attack,Colchicine,DRUG
NCT01385774,SUPER Study; SUPERvised Exercise or Angioplasty for Intermittent Claudication Due to an Iliac Artery Obstruction.,TERMINATED,Study terminated after 240 patients because of slow accrual and lack of additional funding,NA,Intermittent Claudication | Peripheral Arterial Disease,,
NCT01722474,Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.,TERMINATED,"Minor device modifications required, move revised device to clinical site in USA.",NA,Healthy | Diabetes Type 2 | Obesity | Coronary Artery Disease | Peripheral Arterial Disease,,
NCT01747525,Near-Infrared Spectroscopy and Ultrasound Investigation of Coronary Artery Plaque,WITHDRAWN,It was decided not to proceed with the study at this time.,,Coronary Artery Disease | Atherosclerosis,,
NCT00166803,The Impact of Rosiglitazone on Regression of Atherosclerosis,SUSPENDED,no fund,NA,"Diabetes Mellitus, Atherosclerosis",Rosiglitazone,DRUG
NCT00483951,Cardiovascular Disease Screening,TERMINATED,"Per IRB recommendation, a separate protocol will be prepared for retrospective data analysis. The current protocol does not have specific hypotheses.",,Congenital Heart Disease | Atherosclerosis | Myocardial Ischemia | Myocardial Infarction | Acquired Heart Disease,,
NCT01799057,The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication,TERMINATED,The trial has been terminated due to difficulties with recruitment.,PHASE4,Peripheral Arterial Disease | Intermittent Claudication,Metformin,DRUG
NCT01799057,The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication,TERMINATED,The trial has been terminated due to difficulties with recruitment.,PHASE4,Peripheral Arterial Disease | Intermittent Claudication,Placebo,DRUG
NCT03763357,Acute Effects of Leg Heating on Skeletal Muscle Blood Flow,WITHDRAWN,Unable to obtain CT contrast from provider,NA,Peripheral Arterial Disease,,
NCT00527943,Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736),TERMINATED,The trial was terminated at the request of the Data and Safety Monitoring Board.,PHASE3,Atherosclerosis | Myocardial Ischemia | Myocardial Infarction,Vorapaxar,DRUG
NCT00527943,Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736),TERMINATED,The trial was terminated at the request of the Data and Safety Monitoring Board.,PHASE3,Atherosclerosis | Myocardial Ischemia | Myocardial Infarction,Placebo,DRUG
NCT02227368,Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR,TERMINATED,,PHASE2,Peripheral Artery Disease (PAD),Ticagrelor,DRUG
NCT02227368,Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR,TERMINATED,,PHASE2,Peripheral Artery Disease (PAD),Comparator,DRUG
NCT02908490,Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?,TERMINATED,"Slow recruitment, lack of continued funding",PHASE2,"Arthritis, Rheumatoid | Atherosclerosis",Sildenafil,DRUG
NCT00256035,Interleukin-4 (IL-4) as a Marker of Atherosclerosis,WITHDRAWN,,NA,Atherosclerosis | Ischemic Heart Disease,,
NCT01067326,The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis,TERMINATED,Novartis ended all studies regarding Aliskiren.,PHASE3,Endothelial Dysfunction,Aliskiren,DRUG
NCT01067326,The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis,TERMINATED,Novartis ended all studies regarding Aliskiren.,PHASE3,Endothelial Dysfunction,Placebo,DRUG
NCT01114178,Walking Impairment Questionnaire in PAD,TERMINATED,recruitment problem due to administrative process being too long,,Peripheral Artery Disease,,
NCT02313987,Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD,WITHDRAWN,Study never began,,Coronary Atherosclerosis,,
NCT00881257,Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System,TERMINATED,Data was inconclusive,PHASE2|PHASE3,Peripheral Vascular Disease,,
NCT00606333,Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions,TERMINATED,The NEVO™ stent will not be commercialized. Cordis have decided to close the study after 3 years. This decision took the absence of safety signals into account.,NA,Coronary Atherosclerosis,,
NCT00805311,Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis,TERMINATED,Due to the clear advantage of carotid endarterectomy,PHASE4,Carotid Artery Stenosis | Atherosclerosis | Stroke,"atorvastatin, aspirin, losartan, amlodipine",DRUG
NCT02812966,Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon,TERMINATED,new FDA information regarding drug-coated balloons,NA,Peripheral Arterial Disease,,
NCT01391377,Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease,TERMINATED,Tredaptive has been suspended worldwide,NA,Peripheral Arterial Disease,Niacin/Laropiprant combination,DRUG
NCT01391377,Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease,TERMINATED,Tredaptive has been suspended worldwide,NA,Peripheral Arterial Disease,Sugar pill,DRUG
NCT05191862,Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers,TERMINATED,Randomization Error,PHASE1,Intermittent Claudication,Cilostazol 100 mg,DRUG
NCT05191862,Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers,TERMINATED,Randomization Error,PHASE1,Intermittent Claudication,PMR 135 mg,DRUG
NCT03214887,Autologous BMMNC Combined With HA Therapy for PAOD,WITHDRAWN,Incomplete enrollment process,PHASE1|PHASE2,Peripheral Arterial Occlusive Disease | Critical Limb Ischemia,RV-P1501,BIOLOGICAL
NCT01422343,Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease,WITHDRAWN,Shortage of personnel / main study initiator no longer available,,Peripheral Vascular Diseases,,
NCT01159054,Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid,TERMINATED,The funding source is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.,NA,Dialysis | Cardiovascular Disease | Atherosclerosis | Inflammation,Extended Release Nicotinic Acid (Niaspan),DRUG
NCT01633710,Multicentre Study to Investigate the Performance of the Padd Device in the Assessment of Peripheral Arterial Disease,TERMINATED,Redesigned sensor to be subjected to a new protocol,,Peripheral Arterial Disease,,
NCT01104311,Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis,TERMINATED,The enrollment was not done actively even though enrollment period was extended due to poor enrollment.,PHASE4,Brain Ischemia,,
NCT01901224,"Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease",TERMINATED,study was not funded,PHASE4,Peripheral Artery Disease,Metformin 1000 mg,DRUG
NCT01901224,"Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease",TERMINATED,study was not funded,PHASE4,Peripheral Artery Disease,Placebo,DRUG
NCT00892853,Association of Bone Quality and Quantity With Vascular Calcification,WITHDRAWN,,NA,Vascular Calcification | Atherosclerosis | Bone Density,,
NCT01517113,Age-Related Changes in Body Composition,TERMINATED,,,Hypertension | Atherosclerosis,,
NCT03490903,Coronary Angiography THerapeutic Virtual Reality,WITHDRAWN,No patients enrolled,NA,"Virtual Reality | Atherosclerosis | Coronary Artery Disease | Anxiety | Pain, Acute | Vasospasm;Peripheral",Fentanyl Injection,DRUG
NCT03490903,Coronary Angiography THerapeutic Virtual Reality,WITHDRAWN,No patients enrolled,NA,"Virtual Reality | Atherosclerosis | Coronary Artery Disease | Anxiety | Pain, Acute | Vasospasm;Peripheral",Midazolam injection,DRUG
NCT05079906,Assessment of Superficial Femoral Artery Lesions With FFR From the ACIST Navvus® Catheter,WITHDRAWN,Withdrawn due to timing,NA,Peripheral Arterial Disease | Superficial Femoral Artery Stenosis,,
NCT02138032,Effects of Message Content on Intention to Quit Smoking,TERMINATED,Student study which ended at the end of their course.,NA,Peripheral Artery Disease,,
NCT01073111,Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents,WITHDRAWN,,NA,Coronary Artery Disease | Atherosclerosis,,
NCT00982852,Intravascular Ultrasound Derived Virtual Histology and Intracoronary Serum Markers of Inflammation,TERMINATED,Lack of funding,,Coronary Artery Disease | Atherosclerosis | Myocardial Infarction | Heart Failure | Angina,,
NCT02145988,DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease,TERMINATED,Recruitment rate is unexpectedly too low (insufficient number of eligible patients).,PHASE2|PHASE3,Diabetes | Peripheral Arterial Disease,DLBS1033,DRUG
NCT02145988,DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease,TERMINATED,Recruitment rate is unexpectedly too low (insufficient number of eligible patients).,PHASE2|PHASE3,Diabetes | Peripheral Arterial Disease,Placebo,DRUG
NCT00704327,Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition,TERMINATED,Investigator left the Institution,,Cognitive Decline,,
NCT01321476,Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis,WITHDRAWN,Study was never initiated and internal decision to discontinue initiation process,,Heart Disease,,
NCT04505098,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,TERMINATED,The study was suspended by the IRB of record and subsequently terminated,PHASE4,Covid19 | Atherosclerosis | Cardiovascular Diseases | Upper Respiratory Tract Infections,Icosapent ethyl,DRUG
NCT00246493,Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study),TERMINATED,,,Atherosclerosis | Cardiovascular Disease | Vascular Diseases,,
NCT04120610,FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia,TERMINATED,Sponsor decision to terminate study prior to reaching full sample size.,,Peripheral Artery Disease,,
NCT03630835,99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques,WITHDRAWN,Problem of supply of the experimental product (radio tracer).,PHASE2|PHASE3,Carotid Atherosclerosis | Atherosclerotic Plaque,,
NCT03542110,The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial,TERMINATED,Withdrawal of medication and funding support by Sponsor,PHASE4,Saphenous Vein Graft Atherosclerosis,Alirocumab 150 MG/ML subcutaneous injection,DRUG
NCT03542110,The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial,TERMINATED,Withdrawal of medication and funding support by Sponsor,PHASE4,Saphenous Vein Graft Atherosclerosis,Matching Placebo subcutaneous injection,DRUG
NCT04638400,Anti-inflammatory Effects of Simvastatin,TERMINATED,Lack of recruitment- Fellow responsible for study graduated,PHASE4,Inflammation | Atherosclerosis | Hypercholesterolemia,Simvastatin 40mg,DRUG
NCT04638400,Anti-inflammatory Effects of Simvastatin,TERMINATED,Lack of recruitment- Fellow responsible for study graduated,PHASE4,Inflammation | Atherosclerosis | Hypercholesterolemia,Ezetimibe 10mg,DRUG
NCT05031520,PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease,TERMINATED,Study was terminated due to funding expiration.,,Non-Obstructive Coronary Atherosclerosis,Isovue,DRUG
NCT05031520,PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease,TERMINATED,Study was terminated due to funding expiration.,,Non-Obstructive Coronary Atherosclerosis,Nitroglycerin,DRUG
NCT05031520,PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease,TERMINATED,Study was terminated due to funding expiration.,,Non-Obstructive Coronary Atherosclerosis,Metoprolol,DRUG
NCT00234260,Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis),TERMINATED,,,Arteriosclerosis | Hypertension | Heart Diseases,,
NCT05618691,A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC),WITHDRAWN,The study was terminated by sponsor for reasons of adjusted clinical development strategy.,PHASE2,Intermittent Claudication | Peripheral Artery Disease,GFH312,DRUG
NCT03967730,Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication,WITHDRAWN,COVID-19,PHASE1|PHASE2,Peripheral Arterial Disease,,
NCT00106938,Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I),TERMINATED,Business decision and not a result of any patient or product safety issues.,NA,Carotid Artery Disease | Carotid Stenosis | Stroke | Atherosclerosis,,
NCT00000600,Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up,TERMINATED,,PHASE2,Cardiovascular Diseases | Carotid Artery Diseases | Intracranial Arteriosclerosis | Cerebrovascular Disorders | Heart Diseases | Vascular Diseases | Atherosclerosis,Vitamin E,DRUG
NCT00000600,Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up,TERMINATED,,PHASE2,Cardiovascular Diseases | Carotid Artery Diseases | Intracranial Arteriosclerosis | Cerebrovascular Disorders | Heart Diseases | Vascular Diseases | Atherosclerosis,Vitamin C,DRUG
NCT02636283,Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease,TERMINATED,Recruitment,PHASE2,Peripheral Arterial Disease,Entresto,DRUG
NCT02636283,Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease,TERMINATED,Recruitment,PHASE2,Peripheral Arterial Disease,Placebo group,DRUG
NCT00771797,Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment,WITHDRAWN,investigator took study to university hospital duesseldorf,PHASE2,Peripheral Artery Disease,,
NCT01064934,Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a),WITHDRAWN,,NA,Hyperlipoproteinemia(a) | Progressive Cardiovascular Disease,,
NCT03764306,New Ischemic Cerebral Lesions After Endarterectomy vs. Stenting for the Treatment of Symptomatic Carotid Stenosis,TERMINATED,Problem with recruitment of patients meeting the inclusion criteria.,NA,"Carotid Artery Stenosis | Carotid Atherosclerosis | Stroke, Ischemic",,
NCT02215824,"Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia",TERMINATED,,PHASE1,Peripheral Arterial Disease,BIWH 3,DRUG
NCT02215824,"Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia",TERMINATED,,PHASE1,Peripheral Arterial Disease,Placebo,DRUG
NCT03611361,Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients,TERMINATED,Able to reach conclusions about feasibility with number of subjects enrolled.,,Amputation Wound | Peripheral Arterial Disease,,
NCT01683656,ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART,TERMINATED,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,PHASE4,HIV | Atherosclerosis,niacin/laropiprant,DRUG
NCT01683656,ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART,TERMINATED,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.,PHASE4,HIV | Atherosclerosis,Placebo,DRUG
NCT01095237,Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate,TERMINATED,Study has been halted due to safety reasons,NA,Peripheral Arterial Disease | Peripheral Vascular Disease,,
NCT03767686,Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) for Extensive Aortoiliac Occlusive Disease,TERMINATED,Finance stop,,Aorto-Iliac Atherosclerosis | Aortoiliac Obstruction,,
NCT00783796,SPIRIT Small Vessel Registry,TERMINATED,Study stopped at 3 years. Funding for trial withdrawn by sponsor.,NA,Coronary Artery Disease | Atherosclerosis | Myocardial Ischemia,,
NCT01666704,Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis,WITHDRAWN,,PHASE2,Atherosclerotic Cardiovascular Disease,BMS-823778,DRUG
NCT01666704,Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis,WITHDRAWN,,PHASE2,Atherosclerotic Cardiovascular Disease,Placebo matching with BMS-823778,DRUG
NCT03227822,Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease,TERMINATED,Unable to include the number of patients,NA,Peripheral Arterial Disease,,
NCT05480332,Defining the Role of Endothelial Function Assessment Using EndoPAT in Cardiovascular Risk Screening : Comparison to Traditional Risk Assessment Tools and CIMT Testing,WITHDRAWN,Unable to execute internal logistics,,Atherosclerosis,,
NCT00243672,Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques,WITHDRAWN,"The study chair changed his employment, the realization of the study was not possible",PHASE4,Atherosclerosis,Atorvastatin,DRUG
NCT00243672,Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques,WITHDRAWN,"The study chair changed his employment, the realization of the study was not possible",PHASE4,Atherosclerosis,Gemfibrozil,DRUG
NCT01104597,Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians,WITHDRAWN,No subjects were enrolled into the study,NA,Healthy,Nitroglycerin 0.4 mg sublingual,DRUG
NCT02953613,LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:,TERMINATED,unable to identify sufficient eligible patients to meet enrollment goals,,Coronary Artery Disease | Atherosclerosis,,
NCT01154751,Data Registry Following Patients Using Supera Stent in the Femoral Arteries,TERMINATED,"Slow enrollment,increased loss to follow-ups and general lack of interest.",NA,Peripheral Artery Disease | Femoropopliteal Artery Stenosis | Peripheral Vascular Disease,,
NCT04513613,ACHIEVE GRX Registry,WITHDRAWN,Sites have adjusted their participation priorities due to the pandemic. Not enough site interest at this current time to initiate the study.,,Peripheral Arterial Disease | Peripheral Vascular Diseases | Renal Artery Disease | Carotid Artery Diseases,,
NCT02019680,Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels,WITHDRAWN,,,Abnormalities | Hyperlipidemia | Cardiovascular Disease | Arteriosclerosis,,
NCT05468957,Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure,WITHDRAWN,Initiating PI left our institution.,NA,Arterial Occlusion | Cardiovascular Diseases | Atherosclerosis | Hematoma,Statseal,DRUG
NCT02061696,ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System,TERMINATED,Device was modified and no longer available to investigator,NA,Coronary Artery Disease,,
NCT01436123,Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting,TERMINATED,The study was terminated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology,PHASE1,Coronary Artery Disease | Atherosclerosis,,
NCT02388971,Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease,WITHDRAWN,Study has withdrawn.,PHASE2,Atherosclerotic Cardiovascular Disease,MLN1202,DRUG
NCT02388971,Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease,WITHDRAWN,Study has withdrawn.,PHASE2,Atherosclerotic Cardiovascular Disease,Placebo,DRUG
NCT02000661,Routine Versus Selective Use of FFR to Guide PCI,TERMINATED,Stopped early by DSMB due to slow enrollment - obtained data to be analyzed,PHASE4,"Acute Coronary Syndrome | Coronary Atherosclerosis | Angina, Unstable",,
NCT04100681,Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication,TERMINATED,The study was terminated early due to slow recruitment and inability to recruit patients during the Covid-19 situation.,NA,"Peripheral Vascular Disease | Intermittent Claudication | Walking, Difficulty | Critical Limb Ischemia | Ischemia Limb",,
NCT02007525,Yoga to Improve Physical Function and Maximal Walking Distance Among Patients With Peripheral Arterial Disease,TERMINATED,Insufficient enrollment; non-interest by target sample,NA,Peripheral Arterial Disease,,
NCT02388685,Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3,TERMINATED,Inadequate patient recruitment,NA,Peripheral Arterial Disease,,
NCT01326676,Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial,WITHDRAWN,Funding never attained,PHASE3,Cardiovascular Disease,Polypill: Red Heart Pill,DRUG
NCT01326676,Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial,WITHDRAWN,Funding never attained,PHASE3,Cardiovascular Disease,Usual medication,DRUG
NCT02114697,Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging,TERMINATED,The study was stopped when the original principal investigator moved to a new institution.,PHASE4,Atherosclerosis,Statin therapy,DRUG
NCT04338815,Exoskeleton Variability Optimization,TERMINATED,The second arm was not completed since the first arm was not successful based on the convergence criteria.,NA,Peripheral Arterial Disease,,
NCT00243308,Serp-1 for the Treatment of Acute Coronary Syndrome,TERMINATED,Third dose group not recruited due to slow enrollment.,PHASE2,Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis,Serine proteinase-1 (Serp-1),DRUG
NCT01065740,Optimized Supervised Education Program for Peripheral Arterial Disease,TERMINATED,Recruitment Difficulties and Financing Limited and exhausted,NA,Peripheral Arterial Disease,,
NCT00861159,RLIP76 in Human Serum in Adults With Rheumatologic Diseases,WITHDRAWN,Study withdrawn due to lack of staffing resources and subject interest,,Carotid Atherosclerosis,,
NCT00516308,A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease,TERMINATED,Other,PHASE2,Peripheral Vascular Diseases,,
NCT03676842,Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB,TERMINATED,Low enrollment- Hospital during COVID,NA,Peripheral Artery Disease,,
NCT03174522,The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM,TERMINATED,Independent Data Monitoring Committee recommendation to stop due to futility,PHASE3,"Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM) | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 | Cardiovascular Disease | Critical Limb Ischemia (CLI)",REX-001,DRUG
NCT03174522,The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM,TERMINATED,Independent Data Monitoring Committee recommendation to stop due to futility,PHASE3,"Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM) | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 | Cardiovascular Disease | Critical Limb Ischemia (CLI)",Placebo,DRUG
NCT00504088,Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia,TERMINATED,Company decision to halt study,PHASE4,Peripheral Vascular Diseases,,
NCT00673582,Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients,TERMINATED,Sponsor has withdrawn the funding,PHASE4,Atherosclerosis | HIV Infections,Rosuvastatin,DRUG
NCT00673582,Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients,TERMINATED,Sponsor has withdrawn the funding,PHASE4,Atherosclerosis | HIV Infections,Placebo,DRUG
NCT03625089,Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis,WITHDRAWN,Limited funding support,NA,"Arthritis, Rheumatoid | Arthritis, Psoriatic",Atorvastatin,DRUG
NCT03775226,ChampioNIR® SFA Stent EFS Study,TERMINATED,The study objective was achieved. Patients are no longer being examined or receiving intervention.,NA,Peripheral Arterial Disease,,
NCT01230216,Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound,TERMINATED,Slow patients enrollment,PHASE4,Coronary Artery Disease | Hypertension,control systolic blood pressure less than 120 mmHg,DRUG
NCT01230216,Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound,TERMINATED,Slow patients enrollment,PHASE4,Coronary Artery Disease | Hypertension,control systolic blood pressure less than 140 mmHg,DRUG
NCT04123093,Safety and Efficacy of the Noxsano Wound Care Bandage,TERMINATED,"Due to rigorous inclusion criteria and the constraints brought on the health care system from the COVID 19 pandemic which adversely effected enrollment, the sponsor and collaborator have decided to halt enrollment and officially close out the study.",NA,"Wound Heal | Peripheral Artery Disease | Ulcer, Leg | Ulcer Foot | Diabetic Foot Ulcer | Arterial Insufficiency",,
NCT00569686,Lovaza Therapy of Peripheral Arterial Disease,WITHDRAWN,No subject meeting criteria,NA,Peripheral Artery Disease,lovaza,DRUG
NCT00569686,Lovaza Therapy of Peripheral Arterial Disease,WITHDRAWN,No subject meeting criteria,NA,Peripheral Artery Disease,placebo,DRUG
NCT00985478,First in Man Study With SLV342,TERMINATED,Terminated on 14 Sep 2010 due to strategic considerations,PHASE1,Pharmacokinetics,SLV342,DRUG
NCT00985478,First in Man Study With SLV342,TERMINATED,Terminated on 14 Sep 2010 due to strategic considerations,PHASE1,Pharmacokinetics,placebo,DRUG
NCT00228176,Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant,TERMINATED,Company decision taken in light of demands by certain national health authorities,PHASE3,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Rimonabant,DRUG
NCT00228176,Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant,TERMINATED,Company decision taken in light of demands by certain national health authorities,PHASE3,Carotid Artery Plaque | Arteriosclerosis | Obesity | Metabolic Syndrome X,Placebo (for Rimonabant),DRUG
NCT00300040,Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia,TERMINATED,Very slow enrollment.Study entry criteria not in line w/local standards of care,PHASE2,Peripheral Vascular Disease,Hemoglobin glutamer 250 - bovine,DRUG
NCT00300040,Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia,TERMINATED,Very slow enrollment.Study entry criteria not in line w/local standards of care,PHASE2,Peripheral Vascular Disease,6% Hydroxyethylstarch,DRUG
NCT03346577,Endovascular Treatment of Peripheral Artery Disease,TERMINATED,Termination of collaboration,,Peripheral Arterial Disease | Iliac Artery Disease | Below-the-knee Obstruction | Femoropopliteal Occlusive Disease,,
NCT02879019,Walking Training in Peripheral Artery Disease (GrEnADa Sub-study),WITHDRAWN,Study was not started due to lack of funding,NA,Peripheral Artery Disease | Intermittent Claudication,,
NCT03597035,Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On,TERMINATED,The study could not enroll patients owing to the inclusion exclusion criteria,PHASE4,Type2 Diabetes | Hyperkalemia,Spironolactone,DRUG
NCT00926055,Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET),WITHDRAWN,,NA,Atherosclerosis,Ezetrol (Ezetimibe),DRUG
NCT00926055,Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET),WITHDRAWN,,NA,Atherosclerosis,Vytorin (Ezetimibe + Simvastatin),DRUG
NCT00120289,Niacin Plus Statin to Prevent Vascular Events,TERMINATED,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,PHASE3,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,Extended release niacin,DRUG
NCT00120289,Niacin Plus Statin to Prevent Vascular Events,TERMINATED,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.,PHASE3,Cardiovascular Diseases | Heart Diseases | Cerebrovascular Accident | Coronary Disease | Atherosclerosis | Myocardial Infarction,Simvastatin,DRUG
NCT02636062,Predictors of Coronary Artery Calcium Progression in Adults With a Prior Zero Coronary Artery Calcium Score,WITHDRAWN,PI - lack of funding,,Coronary Artery Disease | Endothelial Dysfunction | Atherosclerosis,,
NCT03335020,"Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease",WITHDRAWN,Closed by Investigator,PHASE1,Fibromuscular Dysplasia of Arteries | Segmental Arterial Mediolysis | Spontaneous Coronary Artery Dissection | Atherosclerosis of Artery,Contrast-Enhanced Ultrasound,DRUG
NCT05908513,NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM,WITHDRAWN,Lack of available resources needed to conduct study.,PHASE1,Atherosclerosis of Artery | Peripheral Artery Disease | Diabetes Mellitus | Inflammation | Oxidative Stress,N-acetylcysteine,DRUG
NCT05908513,NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM,WITHDRAWN,Lack of available resources needed to conduct study.,PHASE1,Atherosclerosis of Artery | Peripheral Artery Disease | Diabetes Mellitus | Inflammation | Oxidative Stress,Placebo,DRUG
NCT01809730,Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients,WITHDRAWN,no participants enrolled,,Coronary Artery Disease | Cerebral Vascular Disease | Peripheral Artery Disease | Renal Insufficiency | Diabetes | COPD | Hypertension | Active Smoker | Cancer | CHF | Prior DVT/PE,,
NCT01132768,The Confirmatory Olmesartan Plaque Regression Study,TERMINATED,Low recruitment,PHASE4,Essential Hypertension | Carotid Plaque,Atenolol,DRUG
NCT01132768,The Confirmatory Olmesartan Plaque Regression Study,TERMINATED,Low recruitment,PHASE4,Essential Hypertension | Carotid Plaque,olmesartan medoxomil,DRUG
NCT02440646,Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging,TERMINATED,The study is terminated due to cessation of the research collaboration with Russian institutions,,Coronary Atherosclerosis | Coronary Artery Disease | Contrast-induced Nephropathy | Cerebrovascular Disease | Alzheimer Disease | Chronic Coronary Insufficiency | Stable Chronic Angina,,
NCT02651675,A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH),TERMINATED,Terminated by Sponsor for Business Reasons,PHASE1|PHASE2,Homozygous Familial Hypercholesterolemia (HoFH),,
NCT03493412,Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease,WITHDRAWN,discontinued due to change in operating plans prior to study initiation and enrollment,PHASE4,Peripheral Artery Disease | Peripheral Arterial Disease,"Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)",DRUG
NCT03493412,Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease,WITHDRAWN,discontinued due to change in operating plans prior to study initiation and enrollment,PHASE4,Peripheral Artery Disease | Peripheral Arterial Disease,Placebo,DRUG
NCT02110251,Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease,TERMINATED,Difficulties with including patients,NA,"Peripheral Arterial Disease, Rutherford 4 and 5 With Possibility to Improve Vascularization",,
NCT01417104,Aliskiren Effect on Aortic Plaque Progression,TERMINATED,Safety concerns with approved medication identified in an unrelated trial,PHASE2|PHASE3,Atherosclerosis,Aliskiren,DRUG
NCT01417104,Aliskiren Effect on Aortic Plaque Progression,TERMINATED,Safety concerns with approved medication identified in an unrelated trial,PHASE2|PHASE3,Atherosclerosis,Placebo,DRUG
NCT05648630,Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease,WITHDRAWN,Inadequate participant recruitment,NA,Peripheral Artery Disease (D058729) | Oxidative Stress (D018384) | Inflammation (D007249),,
NCT05361967,Tack Optimized Balloon Angioplasty Post-Market Study,TERMINATED,Terminated due to slow enrollment,,PAD - Peripheral Arterial Disease | PAD | Dissection | Arterial Dissection | Peripheral Arterial Disease | Peripheral Vascular Diseases,,
NCT04043377,68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis,TERMINATED,Financial issues,PHASE3,Coronary Arteriosclerosis,injection of 68Ga-DOTATATE,DRUG
NCT05034848,Peripheral Artery Disease (PAD) : Its Effects on Bone,TERMINATED,no practitionner,NA,Bone | Peripheral Artery Disease,,
NCT00906035,The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD),TERMINATED,Could not enroll subjects who met the stringent inclusion/exclusion criteria.,NA,Peripheral Arterial Disease,Dipyridamole 200mg and Aspirin 25mg bid:,DRUG
NCT00906035,The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD),TERMINATED,Could not enroll subjects who met the stringent inclusion/exclusion criteria.,NA,Peripheral Arterial Disease,Dipyridamole 200 mg bid,DRUG
NCT00906035,The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD),TERMINATED,Could not enroll subjects who met the stringent inclusion/exclusion criteria.,NA,Peripheral Arterial Disease,Aspirin 25 mg bid,DRUG
NCT05699915,Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors,TERMINATED,"Study was stopped due to negative preliminary analysis, slow recruitment (105 patients over 2,5 years), lack of funding, need for more centers, and the changing treatment landscape (approval of ICIs in combination with other cancer treatments).",NA,"Cancer | Immune-related Adverse Event | Cardiac Abnormalities, Variable | Immune Checkpoint Inhibitor-Related Myocarditis | Diastolic Dysfunction | Atherosclerosis | Cardiotoxicity",,
NCT00203632,Glitazones and Endothelial Function (GATE),TERMINATED,Terminated at 50% enrollment due to recent concerns about rosiglitazone,PHASE3,Diabetes Mellitus,rosiglitazone/placebo,DRUG
NCT03734887,Social Engagement Strategies to Improve Medication Adherence,TERMINATED,Inability to complete enrollment caused by COVID-19 and underpowered to conduct analysis,NA,Diabetes | Atherosclerosis Cardiovascular Disease | Congestive Heart Failure | Poor Medication Adherence,,
NCT02460081,"Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease",WITHDRAWN,Discontinued due to significant delays in the expected availability of data.,PHASE2,Diabetic Foot | Peripheral Arterial Disease,PDA-002,DRUG
NCT02460081,"Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease",WITHDRAWN,Discontinued due to significant delays in the expected availability of data.,PHASE2,Diabetic Foot | Peripheral Arterial Disease,Placebo,DRUG
NCT00351364,Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease,TERMINATED,Diffic;ulty recruiting,PHASE4,Coronary Artery Disease | Acute Coronary Syndrome,Montelukast Sodium,DRUG
NCT03111238,The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM,TERMINATED,Stopped due to inactivity,PHASE3,"Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM) | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 | Cardiovascular Disease | Critical Limb Ischemia (CLI)",REX-001,DRUG
NCT03111238,The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM,TERMINATED,Stopped due to inactivity,PHASE3,"Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM) | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 | Cardiovascular Disease | Critical Limb Ischemia (CLI)",Placebo,DRUG
NCT02265146,ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy Study,WITHDRAWN,0,,Coronary Atherosclerosis,,
NCT03994185,The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease,WITHDRAWN,Study was withdrawn by the Sponsor prior to enrollment,NA,Stenosis of Artery | Peripheral Arterial Disease | Iliac Artery Disease | Iliac Artery Occlusion,,
NCT05961163,Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study,TERMINATED,Terminated due to an unusually cold and rainy summer. E.g. in Hamburg the average temperature between 16 July and 15 August 2023 was below 17°C. Collected data will be used to pilot study design and questionnaire. We plan to repeat the study in 2024.,,"Coronary Disease | Myocardial Infarction | Heart Failure | Arrhythmias, Cardiac | Peripheral Artery Disease | Stroke | Ischemic Attack, Transient | Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 | Pulmonary Disease, Chronic Obstructive | Asthma | Renal Insufficiency | Depressive Disorder | Anxiety Disorders | Schizophrenia | Peripheral Nervous System Diseases",,
NCT04073134,The CHORAL Flow Study,TERMINATED,Funding withdrawn,PHASE4,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Evolocumab,BIOLOGICAL
NCT04073134,The CHORAL Flow Study,TERMINATED,Funding withdrawn,PHASE4,Coronary Artery Disease | Atherosclerosis | Hyperlipidemias,Placebo,DRUG
NCT00060996,Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures,TERMINATED,,PHASE3,Critical Limb Ischemia | Peripheral Vascular Disease | Foot Ulcers | Rest Leg Pain,Remodulin® (treprostinil sodium) Injection,DRUG
NCT03277183,"Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin",TERMINATED,Lack of enrollment,PHASE4,Anemia | CKD | Atherosclerosis | Cardiovascular,Low dose erythropoietin,DRUG
NCT03277183,"Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin",TERMINATED,Lack of enrollment,PHASE4,Anemia | CKD | Atherosclerosis | Cardiovascular,High dose erythropoietin,DRUG
NCT03968198,Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.,TERMINATED,organizational difficulties for the collection of adipose tissue and for the supply of the experimental drug,PHASE2,Critical Limb Ischemia and Peripheral Artery Disease,Autologous ASC (for Adipose-derived Stem/Stroma Cell),DRUG
NCT00790764,Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI),SUSPENDED,Suspended due to lack of funding.,PHASE2,Heart Disease | Blocked Arteries | Coronary Ischemia | Coronary Disease | Coronary Artery Disease | Coronary Atherosclerosis,MESENDO,BIOLOGICAL
NCT02407314,Ticagrelor and Peripheral Arterial Disease,TERMINATED,AZ discontinued study,PHASE4,Peripheral Arterial Disease,Aspirin,DRUG
NCT02407314,Ticagrelor and Peripheral Arterial Disease,TERMINATED,AZ discontinued study,PHASE4,Peripheral Arterial Disease,Aspirin + Ticagrelor,DRUG
NCT02975583,Vorapaxar and Lower Extremity Bypass Grafts,WITHDRAWN,We could not secure adequate medication,PHASE4,Peripheral Artery Disease,Vorapaxar,DRUG
NCT02975583,Vorapaxar and Lower Extremity Bypass Grafts,WITHDRAWN,We could not secure adequate medication,PHASE4,Peripheral Artery Disease,Placebos,DRUG
NCT03858764,Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease,WITHDRAWN,no patients enrolled. primary investigator never started study,,Peripheral Arterial Disease | Restenosis,,
NCT02634138,Neuromuscular Electrical Stimulation in Patients With Critical Limb Ischaemia,TERMINATED,Halted prematurely,NA,Peripheral Arterial Disease | Critical Limb Ischaemia,,
NCT00004728,Aspirin Or Warfarin To Prevent Stroke,TERMINATED,,PHASE3,"Stroke | Cerebral Infarction | Atherosclerosis | Constriction, Pathologic",Warfarin,DRUG
NCT00004728,Aspirin Or Warfarin To Prevent Stroke,TERMINATED,,PHASE3,"Stroke | Cerebral Infarction | Atherosclerosis | Constriction, Pathologic",Aspirin,DRUG
NCT04228549,MyPADMGT Support of Out-Patients With Peripheral Arterial Disease,TERMINATED,"Outpatient clinic site unable to provide required recruits due to COVID 19 virus. Terminated June 30 2022. Actual enrolment 126. This information entered August 24, 2022.",NA,Peripheral Arterial Disease,,
NCT01412216,"The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance",TERMINATED,Funding Depleted.,PHASE2,Endothelial Dysfunction | Insulin Resistance | Metabolic Syndrome | Peripheral Arterial Disease,,
NCT01918111,"Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Trial From RENEWAL RDN Registry)",TERMINATED,The study terminated early due to the difficulty of recruiting candidates.,PHASE4,Resistant Hypertension,adenosine infusion treatment,DRUG
NCT01002209,Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery,WITHDRAWN,Changes in the organisation,PHASE2|PHASE3,Diabetes | Peripheral Arterial Disease | Arterial Occlusive Disease,,
NCT00651014,Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405),TERMINATED,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,PHASE4,Hypercholesterolemia | Atherosclerosis,Ezetimibe,DRUG
NCT00651014,Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405),TERMINATED,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.,PHASE4,Hypercholesterolemia | Atherosclerosis,Placebo,DRUG
NCT05575245,Clinical Of Drug-eluting Stent Versus Excimer Laser Ablation Combined Drug-coated Balloon To Treat Arteriosclerosis Occlusive Disease Of Lower Extremity,WITHDRAWN,The research fund has not yet arrived.,NA,Atherosclerosis | Ischemia,,
NCT04573777,Reducing Intracranial atheroSclErosis With Repatha,TERMINATED,Funding Discontinued,PHASE4,Ischemic Stroke,Repatha,DRUG
NCT03773172,Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism,TERMINATED,Early termination due to COVID-19,PHASE2,Cardiovascular Diseases,MEDI6012,DRUG
NCT03773172,Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism,TERMINATED,Early termination due to COVID-19,PHASE2,Cardiovascular Diseases,Placebo,DRUG
NCT00151788,Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.,TERMINATED,,PHASE2|PHASE3,Atherosclerosis | Heterozygous Familial Hypercholesterolemia,Pactimibe sulfate,DRUG
NCT02264288,Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease,TERMINATED,Business decision with all subjects completing at least 1 year follow-up,PHASE2,Peripheral Arterial Disease | Diabetic Foot,3 x 10^6 cells,BIOLOGICAL
NCT02264288,Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease,TERMINATED,Business decision with all subjects completing at least 1 year follow-up,PHASE2,Peripheral Arterial Disease | Diabetic Foot,10 x 10^6 cells,BIOLOGICAL
NCT02264288,Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease,TERMINATED,Business decision with all subjects completing at least 1 year follow-up,PHASE2,Peripheral Arterial Disease | Diabetic Foot,30 x 10^6 cells,BIOLOGICAL
NCT02790957,Plerixafor in Diabetic Wound Healing,TERMINATED,Safety reasons,PHASE2,Diabetes | Wounds | Critical Limb Ischemia,Plerixafor,DRUG
NCT02790957,Plerixafor in Diabetic Wound Healing,TERMINATED,Safety reasons,PHASE2,Diabetes | Wounds | Critical Limb Ischemia,Placebo,DRUG
NCT05063474,Microvascular Reactivity in Peripheral Artery Disease,TERMINATED,Poor enrollment and lack of funding,,Peripheral Artery Disease,,
NCT02825446,Angioplasty of the Tibial Arteries Augmented Radio Frequency Denervation of the Popliteal Artery,TERMINATED,a significant number of patients were not selected,NA,Сhronic Ischemia of the Lower Extremities | Atherosclerosis of the Tibial Arteries | Lesion no More Than Two Tibial Arteries | Steno-occlusive Lesion of the Tibial Arteries,,
NCT05720156,Immunomodulatory Effects of PCSK9 Inhibition,WITHDRAWN,Lack of Feasibility,,"Atherosclerotic Cardiovascular Disease | Cardiovascular Diseases | Atherosclerosis | Arterial Inflammation | Vascular Diseases | Vascular Disease, Peripheral | Vascular Calcification | High Cholesterol/Hyperlipidemia | Heart Diseases | Heart Attack | Stroke | Cerebrovascular Accident | Carotid Artery Diseases | Carotid Atherosclerosis | Transient Ischemic Attack",,
NCT02995642,Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation,WITHDRAWN,Resources not secured,PHASE2,"Aortic Aneurysm, Abdominal | Carotid Atherosclerosis",18F-FPPRGD2,DRUG
NCT03094559,Correlation Between FlowMet™ and Other Gold Standard Assessments in the Management of Critical Limb Ischemia (CLI),WITHDRAWN,Investigator leaving institution,NA,Critical Limb Ischemia,,
NCT00437905,Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial,TERMINATED,,PHASE4,Peripheral Vascular Disease | Intermittent Claudication | Atherosclerosis | Angioplasty,,
NCT01238588,The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan,TERMINATED,The study stopped due to lack of funding.,NA,Dialysis | Cardiovascular Disease | Atherosclerosis | Inflammation | Hyperphosphatemia,Sevelamer Carbonate (Renvela),DRUG
NCT03538392,Serranator® Alto Post Market Clinical Follow Up (PMCF) Study,WITHDRAWN,"Product not available, study withdrawn",,Peripheral Arterial Disease | Arterio-venous Fistula | Arteriovenous Graft,,
NCT06014242,Peripheral Microvascular Resistance as a Predictor for Limb Salvage,WITHDRAWN,Study was never opened to enrollment,NA,Peripheral Arterial Disease,,
NCT04335695,Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life,TERMINATED,Study not feasible-Not able to enroll the patient population,NA,Vascular Diseases | Peripheral Artery Disease | Peripheral Vascular Diseases,,
NCT04822727,"AndraTec PMCF Study : Investigating the AndraTec Guidewires,PTA Balloons and Stents in Iliac Disease.",WITHDRAWN,Sponsor did not pusue with the study,,Iliac Artery Disease | Peripheral Artery Disease,,
NCT03809494,HemaTrate™ in the Treatment of Critical Limb Ischemia,TERMINATED,The study has stopped early due to enrollment challenges related largely to the current pandemic,NA,Critical Limb Ischemia | Ischemia,,
NCT05574166,A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356,TERMINATED,"Only Part 1 was conducted but not Part 2. Due to the low exposures, definitive safety conclusions could not be made for the targeted exposure levels in the future.",PHASE1,Atherosclerosis | Ischemic Stroke,SP-8356,DRUG
NCT05574166,A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356,TERMINATED,"Only Part 1 was conducted but not Part 2. Due to the low exposures, definitive safety conclusions could not be made for the targeted exposure levels in the future.",PHASE1,Atherosclerosis | Ischemic Stroke,Placebo,DRUG
NCT00914316,Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities,TERMINATED,,NA,Peripheral Arterial Disease,Ranolazine,DRUG
NCT00914316,Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities,TERMINATED,,NA,Peripheral Arterial Disease,Placebo,DRUG
NCT00397657,Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis,TERMINATED,"Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.",PHASE4,Atherosclerosis,extended release niacin,DRUG
NCT00397657,Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis,TERMINATED,"Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.",PHASE4,Atherosclerosis,ezetimibe,DRUG
NCT03822195,Lectine Pathway in Unstable Carotid Plaque,WITHDRAWN,PI changed Institution,,Carotid Artery Plaque | Mannose-Binding Lectin Complement Pathway,,
NCT02793349,The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study,TERMINATED,Company have withdrawn the product,NA,Ischemia | Peripheral Arterial Disease (PTA | Arterial Occlusive Diseases,,
NCT00385138,Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.,TERMINATED,Insufficient evidence of the clinical effectiveness of cangrelor,PHASE3,Atherosclerosis | Acute Coronary Syndrome (ACS),Cangrelor,DRUG
NCT00385138,Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.,TERMINATED,Insufficient evidence of the clinical effectiveness of cangrelor,PHASE3,Atherosclerosis | Acute Coronary Syndrome (ACS),clopidogrel,DRUG
NCT00385138,Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.,TERMINATED,Insufficient evidence of the clinical effectiveness of cangrelor,PHASE3,Atherosclerosis | Acute Coronary Syndrome (ACS),Placebo bolus & placebo infusion,DRUG
NCT00385138,Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.,TERMINATED,Insufficient evidence of the clinical effectiveness of cangrelor,PHASE3,Atherosclerosis | Acute Coronary Syndrome (ACS),Placebo capsules - end of PCI,DRUG
NCT00385138,Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.,TERMINATED,Insufficient evidence of the clinical effectiveness of cangrelor,PHASE3,Atherosclerosis | Acute Coronary Syndrome (ACS),Placebo capsules - end of infusion,DRUG
NCT04007055,The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions,TERMINATED,Poor recruitment,PHASE3,"Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Peripheral Vascular Disease | Artery Disease | Peripheral Arterial Occlusive Disease",Ticagrelor 90mg,DRUG
NCT04832308,Mobile Intervention Supervised Exercise Therapy Study 1,WITHDRAWN,Lack of grant funding,NA,"Peripheral Artery Disease | Claudication, Intermittent",,
NCT00856817,Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation,TERMINATED,Recruitment faillure. Similar study published by others. Not yet entered treatment phase.,PHASE4,Atherosclerotic Cardiovascular Disease,L-arginine + heme arginate,DRUG
NCT00856817,Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation,TERMINATED,Recruitment faillure. Similar study published by others. Not yet entered treatment phase.,PHASE4,Atherosclerotic Cardiovascular Disease,Heme arginate + L-arginine,DRUG
NCT03928769,"PROGENitors, TELomeres and ARTerial Aging",SUSPENDED,Covid-19 Pandemics,,Atherosclerosis of Artery,,
NCT02667457,99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis,TERMINATED,Sponsor Decision based on strategic considerations,PHASE2,Carotid Artery Plaque,,
NCT00512031,Characterizing PAI-1 Modulation on Monocyte Adhesion,TERMINATED,Investigator left institution,,Atherosclerosis,,
NCT00067041,Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft,TERMINATED,,PHASE2|PHASE3,Peripheral Vascular Disease,Remodulin (treprostinil sodium) Injection,DRUG
NCT00220831,Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment,TERMINATED,interim analysis showed significant differences between two treatment groups,PHASE2|PHASE3,Diabetes | Myocardial Infarction | Cardiovascular Disease,Natural source Vitamin E 400IU/day,DRUG
NCT03394183,Efficacy of Cardiac Rehab for Patients With Peripheral Artery Disease Versus Patients With Coronary Artery Disease,WITHDRAWN,Insufficient study personnel,NA,Peripheral Arterial Disease | Coronary Artery Disease | Vascular Diseases,,
NCT01019681,Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia,TERMINATED,Only patient enrolled on study died -the cause of death not study related,PHASE1,Critical Limb Ischemia,Cord blood stem cell injection,BIOLOGICAL
NCT03175744,Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries,SUSPENDED,"Patient enrollment impacted by COVID-19 pandemic and other business challenges. Patient enrollment discontinued, but follow-ups will continue according to protocol.",NA,Critical Limb Ischemia,,
NCT01049919,Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI),TERMINATED,"Primary endpoint not met, remaining long-term follow-up not needed.",NA,Critical Limb Ischemia | Peripheral Arterial Disease | Peripheral Vascular Disease,,
NCT00951132,Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy,WITHDRAWN,Failure to include patients,PHASE2,Depression,rosuvastatin,DRUG
NCT00951132,Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy,WITHDRAWN,Failure to include patients,PHASE2,Depression,Placebo,DRUG
NCT02126540,"Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries",WITHDRAWN,,NA,Peripheral Arterial Disease,,
NCT05654935,Telerobotic Ultrasound for Carotid Imaging - Feasibility Study,WITHDRAWN,Failure to procure funding and technical logistics,,Carotid Artery Disease | Atherosclerosis | Atheromatous Plaques | Arteriosclerosis | Vascular Disease | Arterial Occlusive Diseases | Stroke | Cardiac Death | Myocardial Infarction | Coronary Artery Disease | Cardiovascular Disease | Coronary Disease | Coronary Arteriosclerosis | Carotid Arteriosclerosis | Myocardial Ischemia | Heart Diseases | Cerebrovascular Disorders | Peripheral Vascular Disease | Cerebrovascular Accident | Cerebral Infarction,,
NCT01341730,The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT),TERMINATED,,PHASE4,Atherosclerosis | Coronary Artery Disease,Atorvastatin 20mg,DRUG
NCT01341730,The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT),TERMINATED,,PHASE4,Atherosclerosis | Coronary Artery Disease,Atorvastatin 20 mg + Pioglitazone 30 mg,DRUG
NCT00224328,Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia,TERMINATED,The results were not able to be consistantly reproduced. Thus the trial was terminated,,Peripheral Arterial Disease,,
NCT00657514,Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease,WITHDRAWN,Insufficient enrollment,PHASE4,Peripheral Arterial Disease | Angina,Ranolazine,DRUG
NCT00657514,Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease,WITHDRAWN,Insufficient enrollment,PHASE4,Peripheral Arterial Disease | Angina,Placebo,DRUG
NCT01638585,Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia,TERMINATED,recruition number was not reached,PHASE3,Diabetic Foot | Critical Limb Ischemia,urokinase,DRUG
NCT00572949,Magnetocardiography (MCG) in the Diagnosis of Chest Pain Syndrome,WITHDRAWN,sponsor funding,,Chest Pain,,
NCT01341340,The ABSORB BTK (Below The Knee) Clinical Investigation,TERMINATED,Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.,NA,Atherosclerosis | Peripheral Artery Disease | Peripheral Vascular Disease | PAD | Claudication | Critical Limb Ischemia | Lower Limb Disease | Peripheral Arterial Occlusive Disease | PAOD | PVD,,
NCT03119012,P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold,TERMINATED,cannot use bioabsorbable scaffold,PHASE4,Coronary Artery Disease | Stents | Atherosclerosis,Clopidogrel,DRUG
NCT03119012,P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold,TERMINATED,cannot use bioabsorbable scaffold,PHASE4,Coronary Artery Disease | Stents | Atherosclerosis,Ticagrelor,DRUG
NCT03119012,P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold,TERMINATED,cannot use bioabsorbable scaffold,PHASE4,Coronary Artery Disease | Stents | Atherosclerosis,Aspirin,DRUG
NCT04282161,Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System,WITHDRAWN,Business Decision,NA,Peripheral Arterial Disease,,
NCT03054636,Short-term Perfusion Angiography Pilot Study (SPA),TERMINATED,"After data review of enrolled pts, it was determined that initial study objectives would not be met w/ continuation of enrollment",,Peripheral Arterial Disease,,
NCT04197453,The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS),TERMINATED,Sponsor decision,,ASCVD,,
NCT04325932,Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis,WITHDRAWN,,PHASE4,Intracranial Arteriosclerosis | Collateral Circulation | Anterior Cerebral Circulation Infarction,Urinary Kallikrein,DRUG
NCT03318484,Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication,WITHDRAWN,Re-registered,PHASE1|PHASE2,Peripheral Arterial Disease | Atherosclerosis | Cardiovascular Diseases,Optimal Medical Care,DRUG
NCT00942643,Endothelial Damage and Atherosclerosis in Obstructive Sleep Apnea,TERMINATED,Poor patient recruitment,NA,Obstructive Sleep Apnea | Insulin Resistance | Endothelial Function | Oxidative Stress,,
NCT03986697,How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: a Serial CT Study,WITHDRAWN,COVID19 emergency. No patients randomised,PHASE4,Coronary Artery Disease | Hiv,Biktarvy,DRUG
NCT03083444,"P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis",WITHDRAWN,Grant not funded so clinical trial not started.,,"Tooth Eruption, Atherosclerosis",,
NCT00670202,Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis,TERMINATED,Slow enrollment,PHASE2,Carotid Stenosis,Fasudil Hydrochloride,DRUG
NCT00670202,Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis,TERMINATED,Slow enrollment,PHASE2,Carotid Stenosis,Placebo Oral Tablet,DRUG
NCT03942601,Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization,TERMINATED,Halted due to pandemic.,PHASE2,Peripheral Arterial Disease,Temsirolimus,DRUG
NCT03942601,Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization,TERMINATED,Halted due to pandemic.,PHASE2,Peripheral Arterial Disease,Temsirolimus and dexamethasone sodium phosphate,DRUG
NCT01352702,Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,TERMINATED,Slow recruitment; Study was terminated for futility reasons,PHASE4,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Dabigatran,DRUG
NCT01352702,Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,TERMINATED,Slow recruitment; Study was terminated for futility reasons,PHASE4,Coronary Heart Disease | Atrial Fibrillation | Acute Coronary Syndrome | Atherosclerosis,Phenprocoumon,DRUG
NCT00353067,Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina,SUSPENDED,,PHASE3,Acute Coronary Syndrome,veliflapon (DG-031),DRUG
NCT02136706,Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol,WITHDRAWN,Sponsor and site were unable to complete a final contract to support the study,NA,Coronary Artery Disease | Atherosclerosis,,
NCT01599442,Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia,TERMINATED,recrution number was not reached,,Type 2 Diabetes Mellitus | Diabetic Foot | Critical Limb Ischemia,,
NCT02121288,Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients,WITHDRAWN,,PHASE4,Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Intermittent Claudication | Ankle Brachial Index (0.9 or Less),Ticagrelor,DRUG
NCT02121288,Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients,WITHDRAWN,,PHASE4,Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Intermittent Claudication | Ankle Brachial Index (0.9 or Less),clopidogrel,DRUG
NCT02287974,"Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin",TERMINATED,Patients' numebr randomized not achieved. Investigators team with lack of interest and commitment. The sponsor closed prematurely patients' recruitment.,PHASE1|PHASE2,Critical Limb Ischemia (CLI),Stem cell infusion,DRUG
NCT05594979,Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk,TERMINATED,The recruitment period has come to an end and will not be renewed due to insufficient recruitment.,NA,Hypercholesterolemia | Cardiovascular Risk Factor | Dyslipidemias | Atherosclerosis | Cardio-metabolic Risk,,
NCT03946774,Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling,TERMINATED,Temporarily paused due to COVID-19 and expected to resume. This is not a suspension of IRB approval. PI has left the institution.,NA,Dietary Protein,,
NCT05992896,A Study of Loco-Regional Liposomal Bupivacaine Injection,TERMINATED,Lack of funds,PHASE4,Peripheral Arterial Disease,Bupivacaine liposome,DRUG
NCT05992896,A Study of Loco-Regional Liposomal Bupivacaine Injection,TERMINATED,Lack of funds,PHASE4,Peripheral Arterial Disease,Placebo,DRUG
NCT00512369,Effects of PA-1 Transcriptional Regulation on Monocyte Function,TERMINATED,Investigator left institution,,Atherosclerosis,,
NCT01570803,Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease,WITHDRAWN,Study could not be initiated due to lack of research funding from the sponsors.,NA,Arterial Disease | Atherosclerosis,,
